Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Ephrin‐B2 prevents N‐methyl‐D‐aspartate receptor antibody effects on memory and neuroplasticity

Open access
Planagumà, Jesús, Haselmann, Holger, Mannara, Francesco, Petit‐Pedrol, Mar, Grünewald, Benedikt, Aguilar, Esther, Röpke, Luise, Martín‐García, Elena, Titulaer, Maarten J., Jercog, Pablo, Graus, Francesc, Maldonado, Rafael, Geis, Christian, Dalmau, Josep·2016·Annals of Neurology

Abstract

Objective: To demonstrate that ephrin‐B2 (the ligand of EphB2 receptor) antagonizes the pathogenic effects of patients' N‐methyl‐D‐aspartate receptor (NMDAR) antibodies on memory and synaptic plasticity. Methods: One hundred twenty‐two C57BL/6J mice infused with cerebrospinal fluid (CSF) from patients with anti‐NMDAR encephalitis or controls, with or without ephrin‐B2, were investigated. CSF was infused through ventricular catheters connected to subcutaneous osmotic pumps over 14 days. Memory, behavioral tasks, locomotor activity, presence of human antibodies specifically bound to hippocampal NMDAR, and antibody effects on the density of cell‐surface and synaptic NMDAR and EphB2 were examined at different time points using reported techniques. Short‐ and long‐term synaptic plasticity were determined in acute brain sections; the Schaffer collateral pathway was stimulated and the field excitatory postsynaptic potentials were recorded in the CA1 region of the hippocampus. Results: Mice infused with patients' CSF, but not control CSF, developed progressive memory deficit and depressive‐like behavior along with deposits of NMDAR antibodies in the hippocampus. These findings were associated with a decrease of the density of cell‐surface and synaptic NMDAR and EphB2, and marked impairment of long‐term synaptic plasticity without altering short‐term plasticity. Administration of ephrin‐B2 prevented the pathogenic effects of the antibodies in all the investigated paradigms assessing memory, depressive‐like behavior, density of cell‐surface and synaptic NMDAR and EphB2, and long‐term synaptic plasticity. Interpretation: Administration of ephrin‐B2 prevents the pathogenic effects of anti‐NMDAR encephalitis antibodies on memory and behavior, levels of cell‐surface NMDAR, and synaptic plasticity. These findings reveal a strategy beyond immunotherapy to antagonize patients' antibody effects. Ann Neurol 2016;80:388–400

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24721

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 168

Metadata

Authors
Planagumà, J., Haselmann, H., Mannara, F., Petit‐Pedrol, M., Grünewald, B., Aguilar, E., Röpke, L., Martín‐García, E., Titulaer, M. J., Jercog, P., Graus, F., Maldonado, R., Geis, C., & Dalmau, J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2016-08-02
Volume
80
Issue
3
Pages
388-400
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2493627768
Cited by
168
References
7
FWCI
11.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ephrin‐B2 prevents N‐methyl‐D‐aspartate receptor antibody effects on memory and neuroplasticity. https://app.cochat.ai/papers/10.1002/ana.24721
The paper
Planagumà, J., Haselmann, H., Mannara, F., Petit‐Pedrol, M., Grünewald, B., Aguilar, E., Röpke, L., Martín‐García, E., Titulaer, M. J., Jercog, P., Graus, F., Maldonado, R., Geis, C., & Dalmau, J. (2016). Ephrin‐B2 prevents N‐methyl‐D‐aspartate receptor antibody effects on memory and neuroplasticity. Annals of Neurology. https://doi.org/10.1002/ana.24721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.